Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FC008
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,876
Award facts
- Contract value 100% obligated
- $24,876.30 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,876.30 to AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 12, 2026, with an ultimate completion date of the same day. This firm fixed-price delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The contract was awarded on a competitive, non-set-aside basis and specifies performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is part of the Pharmaceutical Prime Vendor program, which supports federal medical procurement needs for military and veteran healthcare systems.
AmerSourceBergen Drug Corp serves as a critical pharmaceutical distributor for the federal government, providing a comprehensive range of medical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The parent company, Cencora, Inc., holds the primary IDC vehicle and demonstrates significant capacity to fulfill government contracts for essential pharmaceutical supplies required by military treatment facilities, veterans' healthcare programs, and other federal medical institutions. As the funding agency, the DLA is advancing its Pharmaceutical Prime Vendor Global Program Generation V initiative, which plans to establish multiple regional contracts with several contractors to ensure robust pharmaceutical supply chain support across defense and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DU26FC008?
SPE2DU26FC008 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DU26FC008 worth?
The government has obligated $24,876 on SPE2DU26FC008.
Is contract SPE2DU26FC008 an order under another contract?
Yes. SPE2DU26FC008 is a delivery order under SPE2DU25D4211, an indefinite delivery contract.
Was contract SPE2DU26FC008 competed?
The extent of competition for SPE2DU26FC008 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award